More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...
The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.
New workspace combines AI-assisted translation, expert medical linguist review, validation workflows, and traceability for ...
Photo provided to China Daily] Drawn by the rich natural resources and supportive policies for young professionals, a 33-year ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief executive officer, effective May ...
An international research team has developed a roadmap for an emerging field of technology called ecotech, which aims to ...
The sector offers buyers a high-quality defensive option, one that could regain interest from investors seeking to reduce ...
NN4101, a first-in-class, connects a fully human anti-c-Kit monoclonal antibody with a vascular endothelial growth factor ...
Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results